tm
Seeing Is Believing
tm
Seeing Is Believing
Theseus Pharmaceuticals's activity chart (see below) currently has 10 price targets and 11 ratings on display.
Analysts average stock forecasts to be materialized ratio is 12.5% with an average time for these price targets to be met of 277.5 days.
Most recent stock forecast was given by ALETHIA YOUNG from CANTOR FITZGERALD on 14-Jul-2023. First documented stock forecast 09-Sep-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 02-Nov-2021
$7
$2.94 (72.41%)
3 years 3 months 10 days ago
(14-Jul-2023)
0/2 (0%)
$4.34 (163.16%)
Buy Since 09-Mar-2023
$23
3 years 3 months 10 days ago
(14-Jul-2023)
0/3 (0%)
$23 (0.00%)
Buy Since 30-Jun-2022
$9
$4.94 (121.67%)
$22
3 years 3 months 10 days ago
(14-Jul-2023)
0/3 (0%)
$9 (0.00%)
Buy Since 02-Nov-2021
$7
$2.94 (72.41%)
$24
3 years 3 months 10 days ago
(14-Jul-2023)
0/2 (0%)
$4.34 (163.16%)
Hold Since 23-May-2023
$24
3 years 5 months 1 days ago
(23-May-2023)
0/1 (0%)
$16.2 (207.69%)
What is THRX (Theseus Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on THRX (Theseus Pharmaceuticals)?
Which analyst has the current lower performing score on THRX (Theseus Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on THRX (Theseus Pharmaceuticals)?
Which analyst is the currently most bullish on THRX (Theseus Pharmaceuticals)?
Which analyst is the currently most reserved on THRX (Theseus Pharmaceuticals)?
